drugset / Trial / NCT00006466
Beta Alethine in Treating Patients With Myeloma
Treatment
Summary
RATIONALE: Biological therapies such as beta alethine use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I/II trial to study the effectiveness of beta alethine in treating patients who have myeloma.
Timeline
- Start
- 2000-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALETHINE | Small molecule | — | Subcutaneous |